ミニメド・グループ
MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.42 | $790M | $13M |
| 2025 Q4 | 0.00 | $724M | $26M |